ACLS Provider: Course

Incorrect. Rapid defibrillation within 1 minute of witnessed VF increases the likelihood of survival and ROSC.

Incorrect. Maintaining a compression fraction above 80% ensures adequate blood flow during resuscitation.

Incorrect. Switching compressors every 2 minutes reduces rescuer fatigue, ensuring high-quality chest compressions are maintained.

Incorrect. Chest compressions should be paused for less than 10 seconds to minimize interruptions during CPR when delivering a shock.

Incorrect. ROSC signifies the resumption of spontaneous cardiac activity with effective circulation, improving patient survival.

Incorrect. Pediatric defibrillation starts at 2 J/kg for the initial shock, increasing as needed based on the patient's response.

Incorrect. Hypothermia is a potentially reversible cause of cardiac arrest and should be addressed during resuscitation.

Incorrect. Two rescuers are needed to maintain high-quality CPR with an advanced airway: one for compressions and one for ventilation.

Incorrect. VF is a shockable rhythm, and immediate defibrillation is the most effective treatment.

Incorrect. Magnesium sulfate stabilizes the cardiac membrane and is the drug of choice for treating torsades de pointes.

Incorrect. Early defibrillation within 30 seconds of a witnessed VF arrest increases survival rates significantly.

Incorrect. Oxygen saturation should be maintained at 92-96% to prevent hypoxia and avoid the harmful effects of hyperoxia.

Incorrect. Continuous chest compressions are performed while ventilations are delivered every 6 seconds when an advanced airway is in place.

Incorrect. PETCO2 monitoring provides real-time feedback on ventilation and the effectiveness of chest compressions.

Incorrect. Pediatric defibrillation starts at 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. Atropine is given at 0.5 mg IV every 3-5 minutes for unstable bradycardia caused by vagal stimulation or primary AV block.

Incorrect. Epinephrine is given every 3-5 minutes to enhance coronary and cerebral perfusion during cardiac arrest.

Incorrect. Targeted temperature management improves neurological outcomes by preventing further brain injury.

Incorrect. The compression-to-ventilation ratio for single-rescuer infant CPR is 30:2, ensuring sufficient oxygenation and circulation.

Incorrect. IM epinephrine is the first-line treatment for anaphylaxis, administered into the mid-thigh for rapid absorption.

Incorrect. The initial dose of adenosine for stable SVT in adults is 6 mg IV, followed by 12 mg if needed for subsequent doses.

Incorrect. High-quality CPR is the primary treatment for asystole, along with epinephrine and addressing reversible causes.

Incorrect. Rotating team roles every 2 minutes prevents fatigue, ensuring consistent delivery of high-quality chest compressions.

Incorrect. Epinephrine is administered every 3-5 minutes during cardiac arrest to maximize coronary and cerebral perfusion.

Incorrect. The correct initial dose of amiodarone for pulseless VT is 300 mg IV/IO, followed by 150 mg for a second dose if needed.

Incorrect. Delivering 10 breaths per minute ensures adequate oxygenation without causing hyperventilation.

Incorrect. A rate of 100-120 compressions per minute optimizes perfusion without compromising cardiac filling.

Incorrect. The correct compression rate for CPR is 100-120 compressions per minute to optimize perfusion and prevent fatigue.

Incorrect. Epinephrine is dosed at 0.01 mg/kg IV/IO during pediatric cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Synchronized cardioversion restores organized cardiac activity in unstable atrial flutter.

Incorrect. Asystole is a non-shockable rhythm requiring immediate high-quality CPR and epinephrine to optimize perfusion.

Incorrect. Adenosine is administered as a rapid IV push to terminate SVT in pediatric patients, followed by a saline flush.

Incorrect. Post-ROSC care focuses on maintaining oxygenation and avoiding hypoxia or hyperoxia to protect organ function.

Incorrect. Asystole is a non-shockable rhythm requiring immediate high-quality CPR and administration of epinephrine.

Incorrect. Amiodarone stabilizes the myocardium and is given as a bolus for refractory VF or pulseless VT.

Incorrect. The most reliable method to confirm and monitor placement by measuring exhaled CO?.

Incorrect. Maximum energy for monophasic defibrillators; for biphasic, follow manufacturer recommendations.

Incorrect. First-line treatment to block vagal stimulation and increase heart rate.

Incorrect. With an advanced airway in place, compressions continue uninterrupted while breaths are delivered at 6-8 breaths per minute.

Incorrect. Naloxone is used to reverse opioid overdose, restoring respiratory effort in patients with respiratory depression.

Incorrect. A supine position ensures proper electrode placement and effective delivery of defibrillation shocks.

Incorrect. Asystole is a non-shockable rhythm requiring immediate CPR and epinephrine administration.

Incorrect. Magnesium sulfate is used to treat torsades de pointes but is not the first-line drug for VF, where epinephrine is prioritized.

Incorrect. ROSC stands for "Return of Spontaneous Circulation," indicating the resumption of a perfusing rhythm.

Incorrect. TTM prevents further neurological injury by maintaining a controlled core temperature after ROSC.

Incorrect. With an advanced airway in place, compressions should continue uninterrupted while providing 10 breaths per minute.

Incorrect. Early stabilization of blood pressure and oxygenation is critical to preventing further cardiac arrest after ROSC.

Incorrect. CPR is the primary treatment for PEA, along with epinephrine and addressing reversible causes to restore circulation.

Incorrect. Pulse checks should be limited to 5-10 seconds to minimize interruptions in chest compressions.

Incorrect. Pediatric defibrillation starts at 2 J/kg to safely deliver an effective shock without causing harm.

Incorrect. Synchronized cardioversion is used for unstable atrial fibrillation to restore organized electrical activity.

Incorrect. Pulseless VT is treated with defibrillation, while synchronized cardioversion is reserved for tachyarrhythmias with a pulse.

Incorrect. PETCO2 monitoring provides real-time feedback on chest compressions and the effectiveness of CPR.

Incorrect. Amiodarone is administered as a 300 mg IV/IO bolus for refractory VF or pulseless VT.

Incorrect. Ventricular fibrillation (VF) is a shockable rhythm and requires immediate defibrillation to restore an organized rhythm.

Incorrect. Asystole is a non-shockable rhythm requiring high-quality CPR and epinephrine administration.

Incorrect. Synchronized cardioversion restores organized cardiac activity in unstable VT with a pulse, preventing progression to VF.

Incorrect. Post-ROSC care focuses on stabilizing ventilation and oxygenation to prevent hypoxia or hyperoxia.

Incorrect. Dopamine is used when atropine is ineffective, improving heart rate and contractility by stimulating beta receptors.

Incorrect. Prompt defibrillation within 30 seconds of witnessed VF arrest improves the chance of restoring a perfusing rhythm.

Incorrect. Amiodarone is the preferred antiarrhythmic for stabilizing wide-complex tachycardia in stable patients.

Incorrect. Post-ROSC care focuses on optimizing oxygenation, ventilation, and hemodynamic stability to prevent further organ damage.

Incorrect. Naloxone blocks opioid receptors and is administered to reverse opioid overdose and restore adequate respiration.

Incorrect. Adenosine 6 mg is given as a rapid IV push for terminating narrow-complex SVT caused by reentrant pathways.

Incorrect. Ventricular fibrillation presents as a disorganized rhythm that requires immediate defibrillation.